SRSF8 is a serine and arginine-rich splicing factor that functions as a regulator of pre-mRNA alternative splicing 1. As an SR protein, SRSF8 binds to RNA and modulates spliceosome activity to determine which exons are included or skipped during mRNA processing 1. In the context of CLK1 pre-mRNA splicing, SRSF8 acts as an exon 4 inclusion activator, working alongside other SR proteins in a complex regulatory network 1. SRSF8 also participates in B7-H3 splicing regulation in colorectal cancer cells, where it contributes to altered B7-H3 expression patterns 2. In cardiac disease, SRSF8 shows strong co-expression with the transcription factor SRF and correlates with alternative splicing events in multiple heart failure subtypes, including non-ischemic and ischemic cardiomyopathy 3. Clinical significance emerges from cancer studies showing that upregulated SRSF8 expression correlates with poor overall survival in prostate cancer patients 4. Additionally, SRSF8 phosphopeptides show increased frequency in Alzheimer's disease plasma, suggesting potential involvement in neurodegenerative disease pathology 5. These findings indicate SRSF8 participates in tissue-specific splicing regulation with implications for cancer progression, cardiovascular disease, and neurodegeneration.